ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

WSJ BLOG/Health: A.M. Vitals: U.S. Officials Defend Testing Regime for Mad Cow Disease

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.) By Mark Long Here's what's making health news this morning: U.S. Defends Safety of Nation's Beef (WSJ): Officials said the testing regimen for mad cow disease is effective and that a diseased cow found in California was never a threat to the food supply, after Indonesia suspended U.S. beef imports. Cuomo Aims to Salvage Health Pact (WSJ): Doctors led by private-practice specialists in and around New York City fear the governor's effort to overhaul out-of-network medical charges will fall apart without legislation to impose price controls on insurers, while health plans say this would make out-of-network care less affordable. Exposure to Violence in Children Harms DNA, Study Says (Los Angeles Times): Duke University researchers found in a long-term study of 118 pairs of twins published in Molecular Psychiatry that boys and girls exposed to violence had shorter telomeres -- the strands of DNA that cap chromosomes. Shortened telomeres have been linked to susceptibility to disease. CDC: Airline Passenger Didn't Have Monkeypox (Associated Press): Officials said a woman's rash wasn't related to the disease, after passengers on a Delta flight from Detroit were kept from disembarking in Chicago for about three hours. FDA Rejects Amgen's Application for Xgeva (Reuters): The risks of expanding use of the osteoporosis drug to delay the spread of bone tumors in patients with advanced prostate cancer was deemed to outweigh the effect of the proposed new application. AstraZeneca CEO Leaving as Profits Slide (WSJ): David Brennan announced he will retire in June as the U.K. drug maker posted a 44% drop in first-quarter profit. Allscripts Plunges After Chairman, Three Directors Leave (Bloomberg News): The electronic-health-records provider fired its chairman after the board "engaged in extensive deliberations" about company leadership, prompting the three directors who disagreed to quit. -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
02/10/201613:38:31Amended Statement of Ownership (sc 13g/a)
02/10/201610:17:35Amended Statement of Ownership (sc 13g/a)
02/09/201618:20:00Panel Recommends FDA Approval of Remicade Knockoff
02/09/201618:16:00Panel Recommends FDA Approval of Remicade Knockoff
02/07/201618:15:00Drug Industry Launches Ad Campaign Aimed at Lawmakers
02/05/201617:06:00Amgen To Present At The Leerink Partners 5th Annual Global Healthcare...
02/04/201616:17:00Phase 3 Study of BLINCYTO® (Blinatumomab) Met Primary Endpoint...
02/04/201616:00:00Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3...
01/28/201616:40:00Amgen Profit Rises 39%; 2016 Outlook Raised
01/28/201616:31:00Amgen Profit Rises 39%; 2016 Outlook Raised
01/28/201616:00:00Amgen's 2015 Revenues Increased 8 Percent To $21.7 Billion And...
01/25/201617:20:00FDA Accepts Amgen's Biosimilar Biologics License Application...
01/25/201616:03:00Amgen Announces Webcast of 2015 Fourth Quarter and Full Year...
01/23/201613:00:00Vectibix® (panitumumab) And Best Supportive Care Improves Overall...
01/22/201601:00:00Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor...
01/21/201616:32:00FDA Approves New Kyprolis® (Carfilzomib) Combination Therapy...
01/11/201612:50:00Celgene Names New CEO, Cuts 2015 Profit Outlook
01/10/201620:33:00Drugmakers Keep Raising Prices Despite Criticisms
01/07/201616:05:00Amgen To Present At The 34th Annual J.P. Morgan Healthcare Conference
12/18/201501:00:00European Commission Approves Amgen's IMLYGIC™ (talimogene laherparepvec) A...

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad